Hosted on MSN2h
Piper Sandler Initiates Coverage of Monopar Therapeutics (MNPR) with Overweight Recommendation
Fintel reports that on January 10, 2025, Piper Sandler initiated coverage of Monopar Therapeutics (NasdaqCM:MNPR) with a ...
Jim Cramer Says Celanese Corporation (CE) ‘Needed China To Recover And It Didn’t’
We recently compiled a list of the 10 S&P 500 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at ...
We are focusing more on quality value than quality growth this year, says Piper Sandler's Kantrowitz
Michael Kantrowitz, Piper Sandler chief investment strategist, joins 'The Exchange' to discuss why higher rates pose the ...
Zawya17h
Futures edge lower on caution ahead of key payrolls data
ET, Dow E-minis were down 66 points, or 0.15%, S&P 500 E-minis were lower 18.25 points, or 0.31% and Nasdaq 100 E-minis were off 78.75 points, or 0.37% ...
Piper Sandler Remains a Hold on Apellis Pharmaceuticals (APLS)
In a report released today, Biren Amin from Piper Sandler maintained a Hold rating on Apellis Pharmaceuticals (APLS – Research Report), with a ...
Piper Sandler Sticks to Their Buy Rating for Repare Therapeutics (RPTX)
Piper Sandler analyst Joseph Catanzaro maintained a Buy rating on Repare Therapeutics (RPTX – Research Report) today and set a price target of ...